Highly different risk estimates for atypical femoral fracture with use of bisphosphonates - debate must be allowed!
Anders
A
Rydholm
D000368:Aged; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005264:Femoral Fractures / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000453:epidemiology; D005598:Fractures, Spontaneous / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D011859:Radiography; D018570:Risk Assessment; D012680:Sensitivity and Specificity
D050071:Bone Density Conservation Agents; D004164:Diphosphonates